AGPAT1 (1-Acylglycerol-3-Phosphate O-Acyltransferase 1) - Structure, Function, and Clinical Relevance

A key enzyme in phospholipid biosynthesis, implicated in metabolic and inflammatory disorders.

Gene Information Card

Symbol AGPAT1
Full Name 1-acylglycerol-3-phosphate O-acyltransferase 1
Gene Type protein-coding
Chromosomal Location 6p21.32
NCBI Gene ID 10554 ncbi.nlm.nih.gov/gene/10554
Ensembl ID ENSG00000204310
UniProt ID Q99943
OMIM ID 603099
HGNC ID 326
Aliases 1-AGP acyltransferase 1, LPAAT-alpha, G15, LPAAT, MGC26232

Description

AGPAT1 encodes 1-acylglycerol-3-phosphate O-acyltransferase 1, an enzyme that catalyzes the conversion of lysophosphatidic acid (LPA) to phosphatidic acid (PA) by adding a fatty acyl group. This reaction is a critical step in the biosynthesis of phospholipids and triglycerides. AGPAT1 is widely expressed and plays a role in lipid metabolism, cell signaling, and membrane biogenesis. Its expression is particularly high in tissues with active lipid metabolism, such as the liver and adipose tissue. Mutations or dysregulation of AGPAT1 have been linked to metabolic disorders and inflammatory conditions.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Metabolic syndrome Altered lipid metabolism due to AGPAT1 dysregulation may contribute to insulin resistance and dyslipidemia. PMID: 21862670 (via NCBI)
Inflammatory bowel disease (IBD) AGPAT1 is located in the MHC region; variants may influence immune response and inflammation. GWAS catalog (via NCBI)
Cancer (various) Aberrant AGPAT1 expression affects phospholipid composition, potentially promoting tumor cell proliferation. COSMIC: mutations found in multiple cancer types

Expression Profile

Tissue Expression
Tissue nTPM level
Liver 19.6 High
Adipose tissue 15.2 Medium
Small intestine 12.8 Medium
Lung 8.5 Low
Brain 5.1 Low
Cell Line Expression
Cell Line nTPM Notes
HepG2 (liver) 18.3 High expression
A549 (lung) 7.2 Moderate
MCF7 (breast) 6.5 Moderate
K562 (leukemia) 3.4 Low
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.584C>T (p.Pro195Leu) Missense 0.01% (gnomAD) May affect enzyme activity; observed in cancer (COSMIC)
c.103G>A (p.Val35Met) Missense 0.02% (gnomAD) Potential impact on protein stability
c.456_457insA (frameshift) Insertion Rare Loss of function; found in tumor samples (COSMIC)
Mutation functional classification

Loss of Function (LOF)

Frameshift and nonsense mutations lead to truncated protein, reducing enzymatic activity, impairing phospholipid synthesis.

Gain of Function (GOF)

No clear gain-of-function mutations reported; overexpression may increase PA production in cancer.

Dominant Negative (DN)

Not documented; possible if mutant protein interferes with dimerization.

Pathways

Glycerophospholipid biosynthesis
Triacylglycerol metabolism
Phosphatidic acid synthesis

Protein Summary

AGPAT1 is a 283-amino acid transmembrane protein localized to the endoplasmic reticulum and mitochondria. It belongs to the lysophosphatidic acid acyltransferase family. The enzyme uses acyl-CoA and lysophosphatidic acid as substrates to produce phosphatidic acid, a precursor for phospholipids and triglycerides. AGPAT1 is involved in lipid droplet formation and signaling. Its activity is regulated by post-translational modifications and interacting partners. Structural studies indicate a conserved acyltransferase domain essential for catalysis.

Related Products

Product name Cat.No. Species Gene ID
AGPAT1 Knockout HEK293 Cell Line EDC12780 Human 10554 Details Get a Quote
AGPAT1 Knockout A-549 Cell Line EDJ-KQ20178 Human 10554 Details Get a Quote
AGPAT1 Knockout HCT 116 Cell Line EDJ-KQ21530 Human 10554 Details Get a Quote
AGPAT1 Knockout HeLa Cell Line EDJ-KQ21531 Human 10554 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: